JP Morgan Chase’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-73,726
Closed -$445K 5962
2019
Q4
$445K Sell
73,726
-485,586
-87% -$2.81M ﹤0.01% 4293
2019
Q3
$2.01M Sell
559,312
-130,257
-19% -$502K ﹤0.01% 3413
2019
Q2
$1.83M Buy
689,569
+125,310
+22% +$370K ﹤0.01% 3445
2019
Q1
$1.67M Sell
564,259
-428,455
-43% -$1.05M ﹤0.01% 3458
2018
Q4
$1.58M Sell
992,714
-46,724
-4% -$132K ﹤0.01% 3450
2018
Q3
$3.83M Buy
1,039,438
+69,270
+7% +$206K ﹤0.01% 2961
2018
Q2
$2.75M Sell
970,168
-64,465
-6% -$220K ﹤0.01% 3154
2018
Q1
$3.84M Sell
1,034,633
-124,424
-11% -$407K ﹤0.01% 2800
2017
Q4
$3.34M Buy
1,159,057
+993,581
+600% +$3.61M ﹤0.01% 2991
2017
Q3
$723K Sell
165,476
-683,860
-81% -$3.04M ﹤0.01% 3679
2017
Q2
$3.9M Buy
849,336
+297,992
+54% +$1.2M ﹤0.01% 2643
2017
Q1
$2.32M Buy
551,344
+102,374
+23% +$425K ﹤0.01% 2951
2016
Q4
$1.85M Buy
448,970
+319,591
+247% +$1.7M ﹤0.01% 3111
2016
Q3
$1.05M Sell
129,379
-604,860
-82% -$5.14M ﹤0.01% 3113
2016
Q2
$5.73M Sell
734,239
-328,516
-31% -$2.82M ﹤0.01% 2197
2016
Q1
$8.21M Sell
1,062,755
-44,218
-4% -$324K ﹤0.01% 1889
2015
Q4
$11.9M Sell
1,106,973
-14,320
-1% -$130K ﹤0.01% 1696
2015
Q3
$7.75M Buy
1,121,293
+246
+0% +$2K ﹤0.01% 1942
2015
Q2
$9.93M Buy
1,121,047
+484,276
+76% +$4.58M ﹤0.01% 1929
2015
Q1
$6.28M Buy
636,771
+293,829
+86% +$3.67M ﹤0.01% 2195
2014
Q4
$4.2M Buy
342,942
+251,104
+273% +$3.07M ﹤0.01% 2511
2014
Q3
$916K Buy
+91,838
New +$852K ﹤0.01% 3389
2013
Q4
Sell
-49,669
Closed -$150K 4327
2013
Q3
$150K Sell
49,669
-239,196
-83% -$1.64M ﹤0.01% 4105
2013
Q2
$2.36M Buy
+288,865
New +$2.21M ﹤0.01% 2689